← Back to home

STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Clinical trials for STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION explained in plain language.

Never miss a new study

Get alerted when new STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION trials appear

Sign up with your email to follow new studies for STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can some stomach cancer patients skip chemo after surgery?

Disease control Recruiting now

This trial is testing whether close follow-up is as good as adjuvant chemotherapy for patients with early-stage (IB-IIA) stomach or gastroesophageal junction cancer after curative surgery. Patients are divided into low-risk and high-risk groups based on factors like lymph node in…

Matched conditions: STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Get alerted when new STAGE IB-IIA ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION trials appear

Can some stomach cancer patients skip chemo after surgery?